TVRD Analyst Ratings
Moderate Buy
6 Buy
1 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
TVRD Stock 12 Month Forecast
Average Price Target
―| Highest Price TargetCHF11.55 | Average Price TargetCHF7.55 | Lowest Price TargetCHF2.48 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
JonesTrading
CHF9.9→CHF8.25
Buy
―
Reiterated
09/15/26
Lucid Capital
CHF4.95→CHF11.55
Buy
―
Initiated
09/08/26
H.C. Wainwright
CHF7.43
Buy
―
Reiterated
08/21/26
Barclays
CHF2.48
Sell
―
Reiterated
08/20/26
BTIG
CHF4.13
Buy
―
Reiterated
08/19/26
Piper Sandler
CHF10.73
Buy
―
Upgraded
07/08/26
Raymond James
CHF8.25
Buy
―
Upgraded
07/08/26
Oppenheimer
CHF8.25
Buy
―
Reiterated
05/11/26
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
JonesTrading
CHF9.9→CHF8.25
Buy
―
Reiterated
09/15/26
Lucid Capital
CHF4.95→CHF11.55
Buy
―
Initiated
09/08/26
H.C. Wainwright
CHF7.43
Buy
―
Reiterated
08/21/26
Barclays
CHF2.48
Sell
―
Reiterated
08/20/26
BTIG
CHF4.13
Buy
―
Reiterated
08/19/26
Piper Sandler
CHF10.73
Buy
―
Upgraded
07/08/26
Raymond James
CHF8.25
Buy
―
Upgraded
07/08/26
Oppenheimer
CHF8.25
Buy
―
Reiterated
05/11/26
Best Analysts Covering Tvardi Therapeutics
3 Months
Success Rate
3/11 ratings generated profit
Average Return
-15.08%
Copying Debanjana Chatterjee's trades and holding each position for 3 Months would result in 27.27% of your transactions generating a profit, with an average return of -15.08% per trade.
1 Year
Success Rate
0/7 ratings generated profit
Average Return
-63.53%
Copying Julian Harrison's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -63.53% per trade.
2 Years
Success Rate
0/7 ratings generated profit
Average Return
-64.96%
Copying Julian Harrison's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -64.96% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
TVRD Analyst Recommendation Trends
Rating
May 26
Jun 26
Jul 26
Aug 26
Sep 26
Strong Buy
6
7
9
11
12
Buy
0
0
0
0
0
Hold
4
4
1
1
1
Sell
2
2
3
5
5
Strong Sell
0
0
0
0
0
total
12
13
13
17
18
Each month's total comprises the sum of three months' worth of ratings.
TVRD Financial Forecast
TVRD Stock Forecast FAQ
What is CH:TVRD’s average 12-month price target, according to analysts?
Based on analyst ratings, Tvardi Therapeutics’s 12-month average price target is 7.55.
What is CH:TVRD’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for CH:TVRD, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Tvardi Therapeutics a Buy, Sell or Hold?
Tvardi Therapeutics has a consensus rating of Moderate Buy, which is based on 6 buy ratings, 1 hold ratings and 1 sell ratings.
What is Tvardi Therapeutics’s share price target?
The average share price target for Tvardi Therapeutics is 7.55. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is CHF11.55 ,and the lowest forecast is CHF2.48. The average share price target represents N/A Increase from the current price of N/A.
The highest analyst share price target is CHF11.55 ,and the lowest forecast is CHF2.48. The average share price target represents N/A Increase from the current price of N/A.
What do analysts say about Tvardi Therapeutics?
Tvardi Therapeutics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 8 Wall Streets Analysts.
How can I buy shares of Tvardi Therapeutics?
To buy shares of CH:TVRD, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.